Ted Wu works as a Professor of medicine at the University of California Davis School of Medicine, Sacramento, Calif, USA. He is the Vice Chief for the Division of Hematology, Chief of the Section of Hematology and Oncology for the VA Northern California Health Care System, and the Director of the Regulatory Knowledge and Support Program for the UC Davis Clinical Translational Sciences Center (CTSC). His main interests are medical education and clinical investigation. His primary areas of research have been in vascular complications of sickle cell disease (SCD) and the association of cancer and thrombosis. He and his colleagues demonstrated significant platelet and leukocyte activation in SCD and described the platelet-erythrocyte aggregates in these patients. Wu has participated in several multicenter therapeutic trials in SCD and is the former Chair of the Sickle Cell Disease Advisory Committee of the National Heart, Lung, and Blood Institute. In collaboration with other investigators at UC Davis and the California Cancer Registry, his group is presently engaged in describing the epidemiology of venous thromboembolism (VTE) in patients with a variety of cancers. This work has identified certain cancer types and predictive factors associated with a high risk of symptomatic VTE. He is a member of ASH, ISTH, ASCO, ACP, AFMR, ASP, and the Society for Clinical and Translation Science.
Biography Updated on 11 January 2011